Published in Antimicrob Agents Chemother on July 01, 1981
Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother (1983) 5.10
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev (1992) 1.84
Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother (1986) 1.32
Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J Clin Microbiol (1983) 1.25
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli. Antimicrob Agents Chemother (1985) 1.02
Effect of filtration on antimicrobial solutions. Antimicrob Agents Chemother (1981) 0.92
Microbiological investigation of cephalosporins. Drugs (1987) 0.83
Evaluation of Mueller-Hinton agar for disk diffusion susceptibility tests. J Clin Microbiol (1983) 0.80
Biographical Feature: Patrick R. Murray, Ph.D. J Clin Microbiol (2016) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother (1980) 23.54
Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing. Appl Microbiol (1970) 8.28
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
In-vitro methods for determining minimal lethal concentrations of antimicrobial agents. Am J Clin Pathol (1979) 4.66
Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage. Antimicrob Agents Chemother (1978) 4.37
Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa. Antimicrob Agents Chemother (1979) 1.69
DIVERSIFICATIONS IN THE TUBE DILUTION TEST FOR ANTIBIOTIC SENSITIVITY OF MICROORGANISMS. Appl Microbiol (1965) 1.53
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1989) 7.92
Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc (1975) 7.01
Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. J Clin Microbiol (1991) 4.91
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med (1993) 4.88
Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol (2003) 4.31
Evaluation of routine subcultures of macroscopically negative blood cultures for detection of anaerobes. J Clin Microbiol (1978) 3.96
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 3.40
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother (1978) 3.29
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 3.02
Clinical laboratory comparison of a slide blood culture system with a conventional broth system. J Clin Microbiol (1982) 2.95
Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis (1995) 2.80
Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis (1986) 2.77
Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 2.71
Comparative evaluation of the Limulus assay and the direct Gram stain for detection of significant bacteriuria. Am J Clin Pathol (1975) 2.69
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Mycobacterial cross contamination during radiometric culturing. J Clin Microbiol (1988) 2.56
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54
Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol (1994) 2.44
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Effects of selective media and atmosphere of incubation on the isolation of group A streptococci. J Clin Microbiol (1976) 2.38
Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother (1977) 2.35
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium. Eur J Clin Microbiol Infect Dis (1990) 2.12
Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother (1983) 2.11
Standardization of the Analytab Enteric (API 20E) system to increase accuracy and reproducibility of the test for biotype characterization of bacteria. J Clin Microbiol (1978) 2.11
Preparation, sensitivity, and specificity of Limulus lysate for endotoxin assay. Appl Microbiol (1973) 2.09
In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 2.09
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.06
Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 2.03
Mycobacterial cross-contamination with the modified BACTEC 460 TB System. Diagn Microbiol Infect Dis (1991) 2.00
Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis (1995) 1.97
Comparison of anaerobic susceptibility results obtained by different methods. Antimicrob Agents Chemother (1979) 1.96
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother (1997) 1.95
Detection of bacteriuria: manual screening test and early examination of agar plates. J Clin Microbiol (1981) 1.94
The accuracy of diagnosing pulmonary tuberculosis at a teaching hospital. Am Rev Respir Dis (1980) 1.92
Comparative evaluation of three identification systems for anaerobes. J Clin Microbiol (1985) 1.90
Xenorhabdus luminescens (DNA hybridization group 5) from human clinical specimens. J Clin Microbiol (1989) 1.88
Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch Intern Med (1984) 1.88
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother (1990) 1.87
Clinical laboratory evaluation of a urine screening device. J Clin Microbiol (1983) 1.83
Clinical evaluation of three urine screening tests. J Clin Microbiol (1987) 1.81
Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob Agents Chemother (1981) 1.77
Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study. J Clin Microbiol (1999) 1.76
Evaluation of the Quantum II and Rapid E identification systems. J Clin Microbiol (1984) 1.76
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria. Eur J Clin Microbiol (1987) 1.76
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
Identification of coagulase-negative staphylococci with the API STAPH-IDENT system. J Clin Microbiol (1983) 1.70
Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2000) 1.70
Effect of calcium on in vitro activity of LY146032 against Clostridium difficile. Antimicrob Agents Chemother (1987) 1.68
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Inactivation of penicillins by Thiol broth. J Clin Microbiol (1982) 1.59
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.59
Reliability of disc diffusion susceptibility testing. Infect Control (1982) 1.57
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med (1983) 1.56
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. J Clin Microbiol (1991) 1.55
Paecilomyces variotii contamination in the lumen of a saline-filled breast implant. Plast Reconstr Surg (1995) 1.54
Use of Mueller-Hinton agar to determine novobiocin susceptibility of coagulase-negative staphylococci. J Clin Microbiol (1982) 1.54
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn Microbiol Infect Dis (1992) 1.53
Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response? Cardiovasc Surg (1999) 1.53
Comparison of automated and rapid manual methods for the same-day identification of Enterobacteriaceae. Am J Clin Pathol (1983) 1.53
Rapid detection of contaminated intravenous fluids using the Limulus in vitro endotoxin assay. Appl Microbiol (1973) 1.52
Modification of the bile solubility test for rapid identification of Streptococcus pneumoniae. J Clin Microbiol (1979) 1.52
Simplified bioassay method for measurement of flucytosine or ketoconazole. J Clin Microbiol (1985) 1.52
Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay. Appl Microbiol (1973) 1.51
Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother (2008) 1.51
Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay. J Clin Microbiol (1978) 1.51
The acid-fast stain: a specific and predictive test for mycobacterial disease. Ann Intern Med (1980) 1.51
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. J Clin Microbiol (1988) 1.44
A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med (1999) 1.41
In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 1.40
Microdilution technique for antimicrobial susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 1.37
Evaluation of the automicrobic system gram-positive identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.35
Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis (1992) 1.33
Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol (1984) 1.33
High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med (1983) 1.33
Sodium polyanethol sulfonate inactivation of aminoglycosides. Antimicrob Agents Chemother (1981) 1.32
Growth of clinical isolates of anaerobic bacteria on agar media: effects of media composition, storage conditions, and reduction under anaerobic conditions. J Clin Microbiol (1978) 1.31
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis (1990) 1.29
In vitro antibacterial activity of cefpiramide. Antimicrob Agents Chemother (1984) 1.28
Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2000) 1.28
Identification of clinical isolates of anaerobic bacteria using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Eur J Clin Microbiol Infect Dis (2012) 1.25
Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J Clin Microbiol (1983) 1.25
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (1993) 1.23
Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species. Eur J Clin Microbiol Infect Dis (2008) 1.21
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Analysis of the interactions between piperacillin, ticarcillin, or carbenicillin and aminoglycoside antibiotics. Antimicrob Agents Chemother (1978) 1.20
Bacitracin differentiation for presumptive identification of group A beta-hemolytic streptococci: comparison of primary and purified plate testing. J Pediatr (1976) 1.20
Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing. Eur J Clin Microbiol Infect Dis (2003) 1.20
Rapid detection of bacterial endotoxins in drinking water and renovated wastewater. Appl Environ Microbiol (1976) 1.20
Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1978) 1.20
Susceptibility testing with anaerobic blood culture isolates. Comparison of a rapid, direct methods with standardized method. Am J Clin Pathol (1980) 1.19
Bacterial interference by oropharynegeal and clinical isolates of anaerobic bacteria. J Infect Dis (1976) 1.15
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. J Clin Microbiol (1986) 1.15
Characterization of Staphylococcus aureus in a pediatric burn unit. Appl Microbiol (1973) 1.14